Tetsuo Ashizawa
Overview
Explore the profile of Tetsuo Ashizawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
185
Citations
3925
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hasan A, Furtado G, Miglorini E, Mergener R, Massuyama B, Barsottini O, et al.
J Neurol
. 2025 Mar;
272(4):261.
PMID: 40067487
Background: Spinocerebellar ataxia type 10 (SCA10), due to an ATTCT repeat expansion in ATXN10, has variable expressivity and the role of presence (ATTCTint +) and absence (ATTCTint-) of interruptions in...
2.
Burt A, LItalien G, Perlman S, Rosenthal L, Kuo S, Ashizawa T, et al.
Mov Disord
. 2025 Mar;
PMID: 40035484
Background: The Patient-Reported Outcome Measure of Ataxia (PROM-Ataxia) has been validated cross-sectionally but not longitudinally. Objective: We aimed to validate PROM-Ataxia as a measure of patient experience of disease over...
3.
Jara-Prado A, Arias-Capistran E, Guerrero-Camacho J, Ochoa-Morales A, Boll M, Davila-Ortiz de Montellano D, et al.
Cerebellum
. 2025 Jan;
24(2):33.
PMID: 39820777
Spinocerebellar ataxia type 10 (SCA10) is an autosomal dominant (AD) neurodegenerative disorder prevalent in the Americas, particularly in Mexico. Clinical manifestations include progressive ataxia and epilepsy. However, it can exhibit...
4.
Rahman W, Hasan M, Islam M, Olubajo T, Thaker J, Abdelkader A, et al.
Proc ACM Interact Mob Wearable Ubiquitous Technol
. 2024 Nov;
7(1).
PMID: 39558922
Many patients with neurological disorders, such as Ataxia, do not have easy access to neurologists, -especially those living in remote localities and developing/underdeveloped countries. Ataxia is a degenerative disease of...
5.
Eisel M, Burns M, Ashizawa T, Byrne B, Corti M, Subramony S
Trends Mol Med
. 2024 Aug;
31(2):181-194.
PMID: 39153956
Recent investigations have defined the pathophysiological basis of many hereditary ataxias (HAs), including loss-of-function as well as gain-of-function mechanisms at either the RNA or protein level. Preclinical studies have assessed...
6.
Rezende T, Petit E, Park Y, Tezenas du Montcel S, Joers J, DuBois J, et al.
Mov Disord
. 2024 Jul;
39(10):1856-1867.
PMID: 39056163
Background: Clinical trials for upcoming disease-modifying therapies of spinocerebellar ataxias (SCA), a group of rare movement disorders, lack endpoints sensitive to early disease progression, when therapeutics will be most effective....
7.
McFarland K, Tiwari A, Hashem V, Zhang L, Zeng D, Vincent J, et al.
Hum Mol Genet
. 2024 Jun;
33(18):1567-1574.
PMID: 38832639
Spinocerebellar ataxia type 10 (SCA10) is a rare autosomal dominant ataxia caused by a large expansion of the (ATTCT)n repeat in ATXN10. SCA10 was described in Native American and Asian...
8.
Petit E, Schmitz-Hubsch T, Coarelli G, Jacobi H, Heinzmann A, Figueroa K, et al.
J Neurol
. 2024 Jun;
271(7):3743-3753.
PMID: 38822840
Background: The Scale for Assessment and Rating of Ataxia (SARA) is a widely used clinical scale to assess cerebellar ataxia but faces some criticisms about the relevancy of all its...
9.
Lai R, Rummey C, Amlang C, Lin C, Chen T, Perlman S, et al.
Mov Disord Clin Pract
. 2024 Feb;
11(5):496-503.
PMID: 38419568
Background: Fatigue is a prevalent and debilitating symptom in neurological disorders, including spinocerebellar ataxias (SCAs). However, the risk factors of fatigue in the SCAs as well as its impact have...
10.
Chatterjee A, Saha S, Chakraborty A, Silva-Fernandes A, Mandal S, Neves-Carvalho A, et al.
PLoS Genet
. 2024 Jan;
20(1):e1011124.
PMID: 38236804
[This corrects the article DOI: 10.1371/journal.pgen.1004749.].